Method of treating cancer with Dll4 antagonist and chemotherapeutic agent

Details for Australian Patent Application No. 2010266004 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Noguera-Troise, Irene; Thurston, Gavin; Thibault, Alain

Agent Watermark

Pub. Number AU-A-2010266004

PCT Pub. Number WO2010/151770

Priority 61/301,881 05.02.10 US; 61/220,465 25.06.09 US

Filing date 25 June 2010

Wipo publication date 29 December 2010

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/151770 Priority application(s): WO2010/151770

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010266010-Fluid injection

2010266003-Biodegradable lawn waste collection system